Carregant...

Oxidative Stress and Proteasome Inhibitors in Multiple Myeloma

Multiple myeloma is a form of plasma cell neoplasm that accounts for approximately 10% of all hematological malignancies. Recently, several novel drugs have been discovered that almost doubled the overall survival of multiple myeloma patients. One of these drugs, the first-in-class proteasome inhibi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmacol Res
Autors principals: Lipchick, Brittany C., Fink, Emily E., Nikiforov, Mikhail A.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5044866/
https://ncbi.nlm.nih.gov/pubmed/26827824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2016.01.029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!